Showing results (111-120 of 325) with videos related to
Sort By:
Pageof 33
Journal of the American College of Cardiology|September 1, 1986
Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainideJ Morganroth, J L Anderson, G D GentzkowCardiology|January 1, 1979
Discrete fibromembranous aortic stenosis in middle age. Natural history and case reportA M Greenspan, J Morganroth, J K PerloffThe Medical Clinics of North America|September 1, 1984
Therapy with conventional antiarrhythmic drugs for ventricular arrhythmiasP F Nestico, N L DePace, J MorganrothThe American Journal of Medicine|February 1, 1985
Acute severe mitral regurgitation. Pathophysiology, clinical recognition, and managementN L DePace, P F Nestico, J MorganrothThe Journal of Antimicrobial Chemotherapy|May 1, 1996
Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety GroupP Jaillon, J Morganroth, I Brumpt, et al.Cardiology Clinics|May 1, 1984
Ventricular arrhythmias. Clinical recognition and managementP F Nestico, N L DePace, J MorganrothAnnals of Internal Medicine|February 1, 1975
Type III hyperlipoproteinemia: an analysis of two contemporary definitionsD S Fredrickson, J Morganroth, R I LevyAnnals of Internal Medicine|February 1, 1975
The biochemical, clinical, and genetic features of type III hyperlipoproteinemiaJ Morganroth, R I Levy, D S FredricksonClinical Pharmacology and Therapeutics|December 17, 2009
Evaluation and management of cardiac safety using the electrocardiogram in oncology clinical trials: focus on cardiac repolarization (QTc interval)J Morganroth, R R Shah, J W ScottPageof 33